By Cocer Peptides 
1 month ago
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.
The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.
Overview
Chronic nonbacterial prostatitis is a common urological condition. Prostamax, a novel therapeutic agent associated with bioactive peptides, plays a role in maintaining prostate health. In the treatment of experimental chronic nonbacterial prostatitis, Prostamax has demonstrated positive effects.
Mechanism of Action
Inflammation Regulation Mechanism: Inflammation is a key factor in the development of chronic non-bacterial prostatitis. Prostamax effectively reduces the intensity of chronic inflammation, alleviating symptoms such as swelling, vascular congestion, and lymphoid infiltration. This effect may be related to its regulation of inflammation-related signaling pathways. It can inhibit the release of certain inflammatory factors or modulate the chemotaxis and activation of inflammatory cells, thereby reducing local inflammatory responses. During inflammation, certain cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) are released in large quantities, triggering an inflammatory cascade that leads to tissue damage and functional impairment. Prostamax may bind to specific receptors on the cell surface, activate intracellular signaling pathways, and inhibit the expression and release of these inflammatory factors, thereby alleviating inflammatory symptoms.
Table 1. The influence of the drug Prostamax on the mass, volume, and density of the ventral portion of the prostate gland in rats with chronic aseptic inflammation.
Cell protection mechanism: Prostamax also has a preventive effect on the development of fibrosis and atrophy processes. Under prolonged inflammatory stimulation, prostate tissue is prone to excessive deposition of extracellular matrix, leading to tissue fibrosis and hardening, while cells may also undergo atrophy due to factors such as inadequate nutrient supply and oxidative stress. Prostamax can maintain the normal morphology and function of cells by promoting cellular metabolism and enhancing antioxidant capacity. It can upregulate the expression of intracellular antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), clear excess reactive oxygen species (ROS) within cells, reduce oxidative stress-induced cellular damage, and thereby prevent cellular atrophy and apoptosis. It also participates in regulating the synthesis and degradation balance of the extracellular matrix, inhibiting the excessive synthesis of fibrosis-related proteins such as collagen, and promoting the expression of matrix metalloproteinases (MMPs) to maintain normal extracellular matrix metabolism and prevent tissue fibrosis.
Regarding reproductive-related regulatory mechanisms: This drug can also enhance an animal's sexual activity. This effect is related to its regulation of the reproductive endocrine system. The prostate, as an important component of the male reproductive system, has its functional state closely related to the levels of reproductive hormones. Prostamax may influence the secretion and action of reproductive hormones such as androgens by regulating the function of the hypothalamus-pituitary-gonadal axis. It promotes the secretion of gonadotropin-releasing hormone (GnRH), which in turn stimulates the pituitary gland to secrete gonadotropins (LH and FSH), promoting testosterone synthesis and secretion in the testes, thereby increasing testosterone levels and enhancing the animal's sexual activity capacity. It can directly act on smooth muscle cells in the prostate and reproductive organs, regulating their contraction and relaxation functions, improving blood circulation in the reproductive organs, and providing a better physiological environment for reproductive activities.
Efficacy
Improving inflammatory symptoms: In the treatment of chronic non-bacterial prostatitis, Prostamax demonstrates significant efficacy in alleviating inflammatory symptoms. Studies have observed that after treatment with Prostamax, swelling of the prostate tissue in experimental animals was significantly reduced, vascular congestion was alleviated, and lymphoid infiltration was decreased. This not only alleviates local pain, heaviness, and other discomfort symptoms in patients but also improves the local microenvironment of the prostate, creating favorable conditions for tissue repair and regeneration. Compared to traditional therapeutic drugs, Prostamax can more effectively control inflammation, reduce the ongoing damage to prostate tissue caused by inflammation, and lower the risk of disease recurrence.
Maintaining prostate tissue structure: By preventing the progression of fibrosis and atrophy, Prostamax helps maintain the normal structure and function of prostate tissue. Fibrosis and atrophy of prostate tissue can lead to a decline in its secretory function, affecting semen quality and composition, and thereby impacting reproductive function. Prostamax can prevent these pathological changes from occurring, maintaining the normal morphology and structure of prostate acini and ducts, ensuring the prostate can normally secrete prostate fluid, and maintaining normal semen liquefaction and sperm motility. This is of significant importance for patients with chronic prostatitis who have fertility needs.
Table 2. The influence of the drug Prostamax on morphometric indices of the prostate gland in rats with chronic prostatitis, % of the standard area of a histological section.
Enhancing reproductive-related functions: Prostamax's ability to enhance sexual activity in animals indirectly reflects its positive impact on the overall function of the reproductive system. In male reproductive health, sexual activity is not only related to sexual function itself but also closely linked to reproductive hormone levels, blood circulation in reproductive organs, and neural regulation. Prostamax improves male reproductive health by regulating these physiological processes. It can improve blood supply to the penile corpus cavernosum, enhance erectile function, and may also increase libido, promoting normal reproductive activity. This represents a comprehensive treatment and improvement approach for patients with sexual dysfunction caused by prostate diseases.
Application
Clinical treatment application: For patients with mild chronic non-bacterial prostatitis, Prostamax can be used alone for treatment, with symptoms monitored for improvement; for moderate to severe cases, it can be combined with antibiotics, alpha-receptor blockers, and other medications for comprehensive treatment to achieve better therapeutic outcomes. During treatment, physicians can assess the efficacy of Prostamax through regular examinations of prostate fluid routine tests, prostate ultrasound, and other indicators, and adjust the treatment plan as needed.
Preventive Health Applications: Given Prostamax's protective effects on prostate tissue and its positive influence on reproductive system function, it also has potential preventive health applications. For high-risk populations for prostate diseases, such as older men or those with a family history of prostate diseases, Prostamax can be considered as a preventive health supplement. By taking Prostamax in small doses over the long term, prostate tissue health can be maintained, and the occurrence of chronic prostatitis, prostate hyperplasia, and other diseases can be prevented. For individuals with mild prostate dysfunction caused by poor lifestyle habits, such as prolonged sitting, excessive alcohol consumption, or overwork, Prostamax can also be used to regulate and improve prostate function, thereby enhancing quality of life. When using Prostamax for preventive health purposes, it is important to note its safety and appropriate dosage, and it should be used under the guidance of a professional doctor or nutritionist.
Figure 1 Side proportion of the prostate rats with chronic prostatitis abacterial receiving Prostamaks. Reducing the amount of collagen fibers as compared to the control. Colouring picrofuchsin. ×200.
Combination therapy application: In the treatment of prostate diseases, single drugs often fail to fully address the complex pathophysiological issues. Prostamax can be used in combination with other treatment methods to achieve synergistic effects. When combined with physical therapy methods such as prostate massage or heat therapy, it can further improve prostate blood circulation, enhance drug penetration and absorption, and enhance treatment efficacy.
Conclusion
As a novel peptide therapy, Prostamax demonstrates advantages in the field of prostate health. From its unique mechanism of action to its significant effects in improving inflammation, maintaining tissue structure, and enhancing reproductive function, as well as its diverse application pathways in clinical treatment, preventive care, and combined therapy, it contributes to the treatment and prevention of prostate diseases.
Sources
[1] Borovskaya T G, Pakhomova A V, Vychuzhanina A V, et al. Experimental studying of the drug efficiency Prostamax in the therapy of chronic aseptic prostatitis and its complications[J]. Modern Research in Inflammation, 2013,3(2):5.DOI:10.4236/mri.2013.23007.
Product available for research use only:
